CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2015-11-16

Name: CHINA PHARMA HOLDINGS, INC.: 10-Q filed 2015-11-16
Creator: CHINA PHARMA HOLDINGS, INC.

What CHINA PHARMA HOLDINGS, INC. reported in its quarterly report filed 2015-11-16 (fiscal Q3 2015): 36 published measures, 98 facts as tagged in accession 0001010549-15-000343.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-16
Fiscal period: fiscal Q3 2015
Accession: 0001010549-15-000343 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	112,683,073	USD
At 2014-12-31	132,081,828	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	25,869,225	USD
At 2014-12-31	25,827,983	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	86,813,848	USD
At 2014-12-31	106,253,845	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-4,148,733	USD	92
2015-01-01 to 2015-09-30	-16,238,028	USD	273
2014-07-01 to 2014-09-30	-6,327,724	USD	92
2014-01-01 to 2014-09-30	-17,361,167	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	651,976	USD	273
2014-01-01 to 2014-09-30	2,596,430	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	0	USD	273
2014-01-01 to 2014-09-30	0	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	4,479,113	USD	92
2015-01-01 to 2015-09-30	15,848,218	USD	273
2014-07-01 to 2014-09-30	5,566,543	USD	92
2014-01-01 to 2014-09-30	18,802,602	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	0	USD	273
2014-01-01 to 2014-09-30	604,756	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-3,343	USD	273
2014-01-01 to 2014-09-30	-4,882,338	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	46,610,873	USD
At 2014-12-31	62,848,901	USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.1	USD/shares	92
2015-01-01 to 2015-09-30	-0.37	USD/shares	273
2014-07-01 to 2014-09-30	-0.15	USD/shares	92
2014-01-01 to 2014-09-30	-0.4	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-0.1	USD/shares	92
2015-01-01 to 2015-09-30	-0.37	USD/shares	273
2014-07-01 to 2014-09-30	-0.15	USD/shares	92
2014-01-01 to 2014-09-30	-0.4	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-18,906	USD	92
2015-01-01 to 2015-09-30	-57,618	USD	273
2014-07-01 to 2014-09-30	-19,215	USD	92
2014-01-01 to 2014-09-30	-57,758	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-3,886,899	USD	92
2015-01-01 to 2015-09-30	-15,358,362	USD	273
2014-07-01 to 2014-09-30	-5,992,089	USD	92
2014-01-01 to 2014-09-30	-16,855,790	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	39,857,891	USD
At 2014-12-31	54,492,543	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-279,113	USD	92
2015-01-01 to 2015-09-30	-915,310	USD	273
2014-07-01 to 2014-09-30	-325,244	USD	92
2014-01-01 to 2014-09-30	-495,054	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	16,126,048	USD
At 2014-12-31	14,171,838	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	11,779,405	USD
At 2014-12-31	24,851,086	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	5,864,582	USD	92
2015-01-01 to 2015-09-30	18,339,345	USD	273
2014-07-01 to 2014-09-30	7,566,238	USD	92
2014-01-01 to 2014-09-30	23,507,722	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-09-30	12,290,243	USD
At 2014-12-31	15,321,856	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	322,000	USD	92
2015-01-01 to 2015-09-30	1,325,300	USD	273
2014-07-01 to 2014-09-30	1,509,063	USD	92
2014-01-01 to 2014-09-30	6,586,846	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	3,720,447	USD	92
2015-01-01 to 2015-09-30	12,667,104	USD	273
2014-07-01 to 2014-09-30	4,057,480	USD	92
2014-01-01 to 2014-09-30	12,215,756	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	405,438	USD	92
2015-01-01 to 2015-09-30	741,116	USD	273
2014-07-01 to 2014-09-30	181,796	USD	92
2014-01-01 to 2014-09-30	2,528,230	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	43,579,557	shares
At 2014-12-31	43,579,557	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-09-30	23,590,204	USD
At 2014-12-31	23,590,204	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-09-30	30,453,919	USD
At 2014-12-31	33,881,878	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-09-30	8,862,709	USD
At 2014-12-31	6,640,718	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-09-30	1,034,058	USD
At 2014-12-31	1,317,221	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	221,856	USD
At 2014-12-31	269,870	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-4,129,827	USD	92
2015-01-01 to 2015-09-30	-16,180,410	USD	273
2014-07-01 to 2014-09-30	-6,308,509	USD	92
2014-01-01 to 2014-09-30	-17,303,409	USD	273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-16,238,028	USD	273
2014-01-01 to 2014-09-30	-17,361,167	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	384,412	USD	92
2015-01-01 to 2015-09-30	1,315,867	USD	273
2014-07-01 to 2014-09-30	422,729	USD	92
2014-01-01 to 2014-09-30	1,229,488	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	2,769,761	USD	273
2014-01-01 to 2014-09-30	1,014,221	USD	273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	460,537	USD	273
2014-01-01 to 2014-09-30	57,758	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	0	USD	273
2014-01-01 to 2014-09-30	0	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	3,314,458	USD	273
2014-01-01 to 2014-09-30	7,671,072	USD	273

Inspect the source

Entity: CHINA PHARMA HOLDINGS, INC. / CIK 0001106644
Captured: 2026-09-20T05:23:28.377Z
SEC response SHA-256: ad45dffd15d0f5a098ab8b6912816a8b1b845b1d791781ea412833d3178873c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001106644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))